Article | December 15, 2020

Five Key Functional Challenges Can Affect Oral Drug Products With An Immediate Release Profile. Ready-To-Use Excipients Can Now Solve Them All.

By Dr. Matthias Wiehn, Global Product Manager Oral Excipients, Evonik

Article #12 December - Evonik.de_205

The market for oral drug products with an immediate release profile continues to move towards the development of more complex dosage forms that are designed to address specific functional or application requirements. In almost every case, the goal is to create oral drug products with functional coatings that are so easy to manufacture and administer that they will optimize patient acceptability and brand preference.

Evonik has been partnering with pharmaceutical companies to overcome a range of development and manufacturing challenges associated with immediate release dosage forms over many years. While each formulation is different based upon factors such as the API, processing method and patient population, we’ve found that customers most commonly want solutions to some combination of the following five key challenges.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online